| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/08/1990 | WO1990001951A1 Molecular conjugates containing cell membrane-blending agents |
| 03/08/1990 | WO1990001944A1 Legionellosis vaccines and methods for their production |
| 03/08/1990 | WO1990001943A2 Treatment of myeloid leukemias by inducing terminal differentiation with interleukin-6 |
| 03/08/1990 | WO1990001942A1 Treatment for malignant melanoma |
| 03/08/1990 | WO1990001941A1 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 03/08/1990 | WO1990001940A1 Atrial natriuretic peptide clearance inhibitors |
| 03/08/1990 | WO1990001927A2 Use of paf antagonists for treating autoimmune diseases |
| 03/08/1990 | WO1990001879A1 Expandable, protein-based, low-calorie compositions |
| 03/08/1990 | WO1990001870A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids |
| 03/07/1990 | EP0357585A2 Preparation active against infections by Pseudomonas aeruginosa, and preparation containing immunoglobulin-G active against Pseudomonas aeruginosa |
| 03/07/1990 | EP0357581A1 Composition for the treatment of erectile dysfunction |
| 03/07/1990 | EP0357510A1 Cyclopeptide derivatives for use as selective inhibitors against active serine protease |
| 03/07/1990 | EP0357332A2 Renin inhibitors useful for the treatment of aids by inhibition of HIV protease |
| 03/07/1990 | EP0357296A1 Combination of t-PA and protein C |
| 03/07/1990 | EP0357240A2 EGF for preventing tissue damage after ischemia |
| 03/07/1990 | EP0357067A2 Recombinant natural killer cell activator |
| 03/07/1990 | EP0356952A2 Process for making flexographic plates with increased flexibility |
| 03/07/1990 | EP0356945A2 Use of the plasminogen activator inhibitor (PAI-2) in immunosuppression |
| 03/07/1990 | EP0356935A2 Inhibition of HIV using transforming growth factor-beta |
| 03/07/1990 | EP0356900A2 Use of drugs containing interferon-gamma for treatment and prevention of primary immunodeficiency |
| 03/07/1990 | EP0356894A1 A novel glycopeptide antibiotic Decaplanin, a process for its production and its use as medicament |
| 03/07/1990 | EP0356836A2 Thrombin-binding substance and process for preparing the same |
| 03/07/1990 | EP0356796A2 Aminomethyl peptides, production process and their use as medicaments |
| 03/07/1990 | EP0356481A1 Purified hemoglobin solutions and method for making same. |
| 03/07/1990 | CN1040222A Process for preparing de-b30-insulins and de-b30-insulins derivs. |
| 03/06/1990 | US4906734 Human conglutinin |
| 03/06/1990 | US4906715 N,N'-divinylalkylurea crosslinked polymers, a process for their preparation, and their use |
| 03/06/1990 | US4906635 Carboxyalkyl dipeptides as antiglaucoma agents |
| 03/06/1990 | US4906616 Hydrolyzed sodium casein compositions for dialysis procedures |
| 03/06/1990 | US4906615 Substituted dipeptides as inhibitors of enkephalinases |
| 03/06/1990 | US4906614 Method of treating posttraumatic nervous injuries with dipeptide derivatives |
| 03/06/1990 | US4906613 Antiglaucoma compositions and methods |
| 03/06/1990 | US4906612 Method for animal growth promotion using glyclopeptides |
| 03/06/1990 | US4906473 Biodegradable poly(hydroxyalkyl)amino dicarboxylic acid) derivatives, a process for their preparation, and the use thereof for depot formulations with controlled delivery of active ingredient |
| 03/06/1990 | US4906468 Insulin activity messengers, their antibodies, and thereof |
| 03/06/1990 | CA1266550A1 Polymer resins with amino acid containing pendants for sorption of bile pigments and bile acids |
| 03/06/1990 | CA1266446A1 Enzymatic detection of bacterial capsular polysaccharide antigens |
| 03/01/1990 | DE3927804A1 Treating auto-immune disease with platelet activating factor - opt. formulated with immunosuppressant, esp. for idiopathic thrombocytopaenic purpura |
| 03/01/1990 | DE3829552A1 Milchbestandteile, verfahren zu ihrer herstellung und mittel, die diese bestandteile enthalten Dairy ingredients, processes for their preparation and products containing these ingredients |
| 03/01/1990 | DE3828582A1 Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren A monoclonal antibody to inhibit the infection of cells by HIV viruses |
| 02/28/1990 | EP0356397A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
| 02/28/1990 | EP0356395A2 Flanking peptides and process for their preparation |
| 02/28/1990 | EP0356339A1 Influenza vaccine and novel adjuvants |
| 02/28/1990 | EP0356223A2 HIV protease inhibitors useful for the treatment of aids |
| 02/28/1990 | EP0356192A2 Prevention & treatment of liver abscesses in animals |
| 02/28/1990 | EP0356180A1 Treatment of myeloid leukemias by inducing terminal differentiation with interleukin-6 |
| 02/28/1990 | EP0356124A2 Atrial natriuretic peptide clearance inhibitors |
| 02/28/1990 | EP0356107A2 Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
| 02/28/1990 | EP0355811A2 Thrombus control agent |
| 02/28/1990 | EP0355794A2 Neuropeptide Y antagonists |
| 02/28/1990 | EP0355793A2 Neuropeptide Y agonists and partial agonists |
| 02/28/1990 | EP0355460A2 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization |
| 02/28/1990 | EP0355409A2 Use of prolylendopeptidase inhibitors in the treatment of AIDS |
| 02/28/1990 | EP0355348A2 Superoxide dismutase composition |
| 02/28/1990 | EP0355142A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 02/28/1990 | EP0355093A1 Human interleukin-3 and muteins thereof |
| 02/28/1990 | CN1040054A Compound having biological activity, and preparing process therefor |
| 02/28/1990 | CN1040033A Amphiphilic peptides and use thereof |
| 02/27/1990 | US4904763 Physiologically-active novel peptides |
| 02/27/1990 | US4904660 Histidine derivatives as superior renin inhibitors |
| 02/27/1990 | US4904643 Immunology |
| 02/27/1990 | US4904642 Therapeutic somatostatin analogs |
| 02/27/1990 | US4904584 Erythropoietin or a colony stimulating factor having lysine replacements and at least one polyoxyalkylene glycol moiety; solubility; pharmacokinetics |
| 02/27/1990 | US4904467 Stabilized interleukin-2 |
| 02/27/1990 | CA1266265A1 Isolation of unreduced oligosaccharides |
| 02/27/1990 | CA1266234A1 Method of binding microflora |
| 02/22/1990 | WO1990001555A1 A process for enzymatic production of dipeptides or structurally related compounds |
| 02/22/1990 | WO1990001547A1 Methods for isolating herpes virus thymidine kinase-encoding dna |
| 02/22/1990 | WO1990001496A1 Polypeptides and dna encoding same |
| 02/22/1990 | WO1990001494A1 Polypeptide pertussis toxin vaccine |
| 02/22/1990 | WO1990001338A1 Leukocyte adhesion inhibitor |
| 02/22/1990 | WO1990001336A1 Novel infectious bursal disease virus |
| 02/22/1990 | WO1990001334A1 Formulations for plasminogen activator using aspartate |
| 02/22/1990 | WO1990001332A1 Plasminogen activator-heparin conjugates |
| 02/22/1990 | WO1990001331A1 Wound healing |
| 02/22/1990 | WO1990001330A1 Use of neuromedins u8 and u25 as therapeutic compounds |
| 02/22/1990 | WO1990001329A1 Enteric formulations of physiologically active peptides and proteins |
| 02/22/1990 | WO1990001328A1 Tnf and formulations thereof in the treatment or prophylaxis of hepatitis b |
| 02/22/1990 | WO1988007551A3 Growth factor receptor |
| 02/21/1990 | EP0355065A1 Renin inhibitory peptides containing suleptanic acid or derivatives thereof |
| 02/21/1990 | EP0355047A1 Purified protein A compositions and methods for their preparation |
| 02/21/1990 | EP0354992A2 Conjugates of VIP and active fragments thereof with hydrophobic moieties and topical compositions for use in the treatment of male impotence |
| 02/21/1990 | EP0354989A1 Megakaryocytopoietin, preparation and use |
| 02/21/1990 | EP0354934A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
| 02/20/1990 | US4902783 Adsorption with silica gel, adsorption with activated carbon, density gradient centrifuging and equilibrium density gradient centrifuging |
| 02/20/1990 | US4902781 Novel tripetide derivatives |
| 02/20/1990 | US4902708 CCK antagonists |
| 02/20/1990 | US4902680 Gonadotrophin, hormones |
| 02/20/1990 | US4902623 Contacting with immobilized kunitz-type inhibitor from erythrina species |
| 02/20/1990 | US4902509 Process for the isolation of chicken egg cystatin, antiviral agents containing it and its use as viral protease inhibitor |
| 02/20/1990 | US4902505 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 02/20/1990 | US4902500 Polyoxypropylene-polyoxyethylene block polymer and phospholipid |
| 02/20/1990 | CA1266047A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use |
| 02/15/1990 | DE3926658A1 Fettsaeurezusammensetzung Fettsaeurezusammensetzung |
| 02/15/1990 | DE3826963A1 Pharmaceutical composition for oral administration containing metal complexing agents and metal salts |
| 02/15/1990 | DE3826962A1 Pharmaceutical composition for oral administration containing non-absorbable metal complexing agents |
| 02/14/1990 | EP0354855A2 Liposomes on which adsorption of proteins is inhibited |
| 02/14/1990 | EP0354820A2 Novel peptide derivatives and anti-dementia agents |
| 02/14/1990 | EP0354819A2 Novel peptide and anti-dementia agent |
| 02/14/1990 | EP0354592A1 A novel human physiologically active polypeptide |